drugset / Trial / NCT04813016

Intraperitoneal Tramadol Versus Dexmedetomedine for Analgesia After Abdominal Laparoscopic Cancer Surgeries

NCT04813016

Phase 2/3 Completed 100 enrolled National Cancer Institute, Egypt
RandomizedParallel-groupDouble-blindTreatment

Summary

Multiple modalities for postoperative analgesia after laparoscopic procedures has been used, of them intraperitoneal route (IP) was used to decrease the analgesic requirements. Both early and late bupivacaine and tramadol versus bupivacaine and dexmedetomedine will be tried to choose which is having a better analgesic profile.

Timeline

Start
2021-03-01
Primary completion
2022-04-30
Completion
2022-05-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 1 ug/kg
Comparator Tramadol Other / unclassified 150 mg
Background Bupivacaine Other / unclassified 0.25 % Other

Indications

No indication recorded.